Lightstone Ventures is a leading global venture capital firm.
Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 1, 2022
Carrick Therapeutics
|
Series C | $60M | Biotechnology | — |
Sep 12, 2022
Nimbus Therapeutics
|
Series Unknown | $125M | Biotechnology | — |
Jan 11, 2022
ProVerum Medical
|
Series A | €30M | Health Care | Yes |
Apr 15, 2021
Alchemab Therapeutics
|
Series A | £60M | Biotechnology | — |
Sep 22, 2020
Willow
|
Series C | $55M | Child Care | Yes |